Clinical trial
Stem Cell Factor Medication for Aplastic Anemia
NCT00001398 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00001398 |
|---|---|
| Title | Stem Cell Factor Medication for Aplastic Anemia |
| Official title | A Phase I/II Trial of Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) in Patients Diagnosed With Acquired Aplastic Anemia |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Aplastic Anemia, Pancytopenia |
| Intervention type | Drug |
| Interventions | Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) |
| Enrollment | 40 |
| Start date | Oct 1, 1993 |
| Completion | Jun 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: